Citation

Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G.: BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies. J Med Chem, Volume 64 (17), 2021

Authors

Bader B, Bartels F, Berger M, Bömer U, Briem H, Buchgraber P, Eberspächer U, Eis K, Hammer S, Lienau P, Lücking U, Moosmayer D, Mumberg D, Nising CF, Rehwinkel H, Schatz CA, Siemeister G., Wang Q, Wengner AM, Wortmann L, Zitzmann-Kolbe S

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c00762

PubMed

34428039

Machine-readable

REST APIRDF